These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 34708581

  • 21. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
    Li M, Li AQ, Zhou SL, Lv H, Wei P, Yang WT.
    J Exp Clin Cancer Res; 2020 May 24; 39(1):92. PubMed ID: 32448269
    [Abstract] [Full Text] [Related]

  • 22. Identification of mRNAs that are spliced but not exported to the cytoplasm in the absence of THOC5 in mouse embryo fibroblasts.
    Guria A, Tran DD, Ramachandran S, Koch A, El Bounkari O, Dutta P, Hauser H, Tamura T.
    RNA; 2011 Jun 24; 17(6):1048-56. PubMed ID: 21525145
    [Abstract] [Full Text] [Related]

  • 23. Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative Breast Cancer.
    Troschel FM, Minte A, Ismail YM, Kamal A, Abdullah MS, Ahmed SH, Deffner M, Kemper B, Kiesel L, Eich HT, Ibrahim SA, Götte M, Greve B.
    Int J Mol Sci; 2020 Mar 21; 21(6):. PubMed ID: 32245259
    [Abstract] [Full Text] [Related]

  • 24. BOP1 confers chemoresistance of triple-negative breast cancer by promoting CBP-mediated β-catenin acetylation.
    Li S, Wu H, Huang X, Jian Y, Kong L, Xu H, Ouyang Y, Chen X, Wu G, Yu L, Wang X.
    J Pathol; 2021 Jul 21; 254(3):265-278. PubMed ID: 33797754
    [Abstract] [Full Text] [Related]

  • 25. Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness.
    Shin VY, Chen J, Cheuk IW, Siu MT, Ho CW, Wang X, Jin H, Kwong A.
    Cell Death Dis; 2019 Mar 20; 10(4):270. PubMed ID: 30894512
    [Abstract] [Full Text] [Related]

  • 26. Downregulation of TAB182 promotes cancer stem-like cell properties and therapeutic resistance in triple-negative breast cancer cells.
    He H, Wang S, Zhang W, Gao S, Guan H, Zhou P.
    BMC Cancer; 2023 Nov 13; 23(1):1101. PubMed ID: 37953246
    [Abstract] [Full Text] [Related]

  • 27. TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer.
    Ma Y, Zhang H, Chen C, Liu L, Ding T, Wang Y, Ma D, Ling X, Chen X, Li J, Guansheng, Zhong, Ru G, Zhang L, Tang J.
    Oncogene; 2022 Mar 13; 41(11):1589-1599. PubMed ID: 35091679
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
    Ring A, Kaur P, Lang JE.
    BMC Cancer; 2020 Nov 10; 20(1):1076. PubMed ID: 33167919
    [Abstract] [Full Text] [Related]

  • 31. HES1 promotes breast cancer stem cells by elevating Slug in triple-negative breast cancer.
    Li X, Li Y, Du X, Wang X, Guan S, Cao Y, Jin F, Li F.
    Int J Biol Sci; 2021 Nov 10; 17(1):247-258. PubMed ID: 33390847
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H, Wu T, Xie D, Li D, Hua K, Hu J, Fang L.
    Cell Physiol Biochem; 2018 Nov 10; 48(5):1968-1982. PubMed ID: 30092563
    [Abstract] [Full Text] [Related]

  • 35. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
    Li M, Li A, Zhou S, Lv H, Yang W.
    J Hematol Oncol; 2019 Feb 08; 12(1):14. PubMed ID: 30736840
    [Abstract] [Full Text] [Related]

  • 36. Chemotherapy-induced adenosine A2B receptor expression mediates epigenetic regulation of pluripotency factors and promotes breast cancer stemness.
    Lan J, Wei G, Liu J, Yang F, Sun R, Lu H.
    Theranostics; 2022 Feb 08; 12(6):2598-2612. PubMed ID: 35401817
    [Abstract] [Full Text] [Related]

  • 37. Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells.
    Xu Z, Liu C, Zhao Q, Lü J, Ding X, Luo A, He J, Wang G, Li Y, Cai Z, Wang Z, Liu J, Liu S, Li W, Yu Z.
    Pharmacol Res; 2020 Feb 08; 152():104628. PubMed ID: 31904506
    [Abstract] [Full Text] [Related]

  • 38. IMP3 promotes TNBC stem cell property through miRNA-34a regulation.
    Huang QD, Zheng SR, Cai YJ, Chen DL, Shen YY, Lin CQ, Hu XQ, Wang XH, Shi H, Guo GL.
    Eur Rev Med Pharmacol Sci; 2018 May 08; 22(9):2688-2696. PubMed ID: 29771420
    [Abstract] [Full Text] [Related]

  • 39. ANP32E induces tumorigenesis of triple-negative breast cancer cells by upregulating E2F1.
    Xiong Z, Ye L, Zhenyu H, Li F, Xiong Y, Lin C, Wu X, Deng G, Shi W, Song L, Yuan Z, Wang X.
    Mol Oncol; 2018 Jun 08; 12(6):896-912. PubMed ID: 29633513
    [Abstract] [Full Text] [Related]

  • 40. Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression.
    Huang TT, Tseng LM, Chen JL, Chu PY, Lee CH, Huang CT, Wang WL, Lau KY, Tseng MF, Chang YY, Chiang TY, Ueng YF, Lee HC, Dai MS, Liu CY.
    EBioMedicine; 2020 Apr 08; 54():102717. PubMed ID: 32268268
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.